← Leaderboards
William T Abraham
University Of Colorado Denver
$413,706
Attributed
$413,706
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$413,706 · 1
By mechanism
M01$413,706 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Robert Turner Schooley$73,100,957
- Robert W Schrier$16,805,433
- Georgeanna J Klingensmith$5,235,761
- Raphael A. Nemenoff$15,000,654
- John G. Gerber$1,597,914
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical Trial Phase ICongestive Heart FailureDrug Screening /EvaluationHeart Disorder ChemotherapyHormone InhibitorHormone ReceptorHuman SubjectHuman Therapy EvaluationPharmacokineticsVasopressins
Grant awards (5)
ASCENDING MULTIDOSE CI PHARM STUDY VPA-985 PTS W/CHRONIC CONGESTIVE HEART FAILURE$190,747
M01 · FY2002 · RR
ASCENDING MULTIDOSE CI PHARM STUDY VPA-985 PTS W/CHRONIC CONGESTIVE HEART FAILURE$190,747
M01 · FY2001 · RR
ASCENDING MULTIDOSE CI PHARM STUDY VPA-985 PTS W/CHRONIC CONGESTIVE HEART FAILURE$0
M01 · FY2001 · RR
ASCENDING MULTIDOSE CI PHARM STUDY VPA-985 PTS W/CHRONIC CONGESTIVE HEART FAILURE$32,212
M01 · FY2000 · RR
ASCENDING MULTIDOSE CI PHARM STUDY VPA-985 PTS W/CHRONIC CONGESTIVE HEART FAILURE$0
M01 · FY2000 · RR